Your browser doesn't support javascript.
COVID-19 Pandemic and Dysbiosis: Can the Ivermectin Hysteria Lead to an Increase of Autoimmune Neuroinflammatory Diseases?
Peron, J P S; Nakaya, H I; Schlindwein, M A M; Gonçalves, Marcus Vinicius Magno.
  • Peron JPS; Neuroimmune Interactions Laboratory, Institute of Biomedical Sciences, Department of Immunology, University of Sao Paulo, São Paulo, Brazil; Scientific Platform Pasteur, University of São Paulo (USP), São Paulo, Brazil; Immunopathology and Allergy Post Graduate Program, School of Medicine, Universit
  • Nakaya HI; Scientific Platform Pasteur, University of São Paulo (USP), São Paulo, Brazil; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo (USP), São Paulo, Brazil.
  • Schlindwein MAM; Department of Medicine, University of the Region of Joinville (UNIVILLE) Joinville, Brazil.
  • Gonçalves MVM; University of the Region of Joinville (UNIVILLE), Joinville, Brazil.
Crit Rev Immunol ; 40(6): 537-542, 2020.
Article in English | MEDLINE | ID: covidwho-1050522
ABSTRACT
The pandemic caused by the SARS-CoV-2 has made new treatments a goal for the scientific community. One of these treatments is Ivermectin. Here we discuss the hypothesis of dysbiosis caused by the use of Ivermectin and the possible impacts on neuroinflammatory diseases after the end of the pandemic.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Dysbiosis / SARS-CoV-2 / COVID-19 Type of study: Observational study Topics: Long Covid Limits: Humans Language: English Journal: Crit Rev Immunol Journal subject: Allergy and Immunology Year: 2020 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Dysbiosis / SARS-CoV-2 / COVID-19 Type of study: Observational study Topics: Long Covid Limits: Humans Language: English Journal: Crit Rev Immunol Journal subject: Allergy and Immunology Year: 2020 Document Type: Article